Oncogenes y Dianas Efectoras
PANCCUN
Washington University in St. Louis School of Medicine
San Luis, Estados UnidosPublicaciones en colaboración con investigadores/as de Washington University in St. Louis School of Medicine (2)
2020
-
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
Nature Medicine, Vol. 26, Núm. 6, pp. 878-885
2015
-
Bone metastases in lung cancer: Potential novel approaches to therapy
American Journal of Respiratory and Critical Care Medicine, Vol. 192, Núm. 7, pp. 799-809